News & Press Releases

Stay updated with the latest news and press releases from Fe Pharmaceuticals, highlighting our advancements and breakthroughs in therapeutic solutions.

July 23, 2024

Fe Pharmaceuticals Announces Issuance of New U.S. Patent for Its Lead Product, DIBI

Fe Pharmaceuticals, is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,024,490, titled "Polymeric Metal Chelating Compositions and Methods of Preparing Same for Controlling Growth and Activities of Living Cells and Organisms for Therapeutic Use in Treating Diseases in Animals, Fish or Humans".

June 12, 2023

Fe Pharmaceuticals Names Anne-Marie Duliege Chairperson of the Board

Fe Pharmaceuticals (Canada) and its US subsidiary, Fe Pharmaceuticals, announced today that Anne-Marie Duliege, has been elected as Chairperson of the Board of Directors of the company.

September 23, 2020

Fe Pharmaceuticals Launches US Subsidiary, Names New Independent Board Members

Fe Pharmaceuticals (Canada) has created a new US subsidiary, Fe Pharmaceuticals, to develop DIBI, a non-toxic, iron-binding copolymer, as a potent, broad-spectrum, antimicrobial agent active against bacterial and fungal infections...

September 23, 2020

Chelation Partners’ Preclinical Anti-infective Polymer Improves Survival in Bacterial Sepsis

Chelation Partners, a preclinical company focused on medical indications related to iron availability including infectious disease, cancer and inflammatory disorders, today announced the publication of positive preclinical results...

July 23, 2020

Chelation Partners Announces Issuance of U.S. Patent Covering Composition of Matter for DIBI and Related Compounds for Controlling Infections

Chelation Partners, a Canadian company focused on medical indications related to iron availability including infectious disease, cancer and inflammatory disorders, announced today that the U.S. Patent and Trademark Office

June 9, 2020

Chelation Partners’ Lead COVID-19 Product Shows Promise for Sepsis

Chelation Partners is a Canadian company focused on medical indications related to iron availability including infectious disease, cancer and inflammatory disorders.